Tempus AI, Inc. (TEM)

TEM Financials

TEM Quarterly Income Statement (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Gross Profit	948.825M	218.341M	329.539M	205.906M	195.039M	155.203M	122.064M	105.839M	75.513M
Revenue	1.364B	348.116M	367.211M	334.206M	314.635M	255.737M	200.680M	180.929M	165.969M
Cost of Goods Sold	415.343M	129.775M	37.672M	128.300M	119.596M	100.534M	78.616M	75.090M	90.456M
Gross Profit Margin	62.7%	62.7%	89.7%	61.6%	62.0%	60.7%	60.8%	58.5%	45.5%
Total Operating Expenses	1.196B	295.656M	377.767M	265.850M	256.813M	223.892M	172.764M	159.455M	609.005M
Research & Development	276.987M	45.921M	71.918M	83.047M	76.101M	69.265M	61.476M	58.028M	145.933M
Selling, General & Administrative	784.617M	212.594M	208.508M	182.803M	180.712M	154.627M	111.288M	101.427M	463.072M
Operating Income (EBIT)	-247.261M	-77.315M	-48.228M	-59.944M	-61.774M	-68.689M	-50.700M	-53.616M	-533.492M
Operating Margin	-22.2%	-22.2%	-13.1%	-17.9%	-19.6%	-26.9%	-25.3%	-29.6%	-321.4%
Income Before Tax (EBT)	-308.476M	-125.981M	-60.158M	-79.706M	-42.631M	-114.217M	-12.892M	-75.802M	-552.117M
Interest Income	14.681M	3.866M	5.122M	4.600M	1.093M	1.813M	3.546M	4.789M	1.718M
Interest Expense	151.203M	14.341M	99.884M	15.399M	21.579M	18.003M	13.359M	13.761M	13.295M
Other Income/Expense	-61.215M	-48.666M	-11.930M	-19.762M	19.143M	-45.528M	37.808M	-22.186M	-18.625M
Net Income	-302.910M	-125.919M	-54.166M	-79.982M	-42.843M	-68.037M	-13.014M	-75.840M	-552.212M
Income Tax Expense	-5.566M	-62K	-5.992M	276K	212K	-46.180M	122K	38K	95K
Net Profit Margin	-36.2%	-36.2%	-14.8%	-23.9%	-13.6%	-26.6%	-6.5%	-41.9%	-332.7%
EBITDA	-233.844M	-85.465M	-120.183M	-37.276M	9.080M	-73.978M	12.460M	-50.909M	-529.663M
EBITDA Margin	-24.6%	-24.6%	-32.7%	-11.2%	2.9%	-28.9%	6.2%	-28.1%	-319.1%
Depreciation & Amortization	9.910M	26.175M	-71.328M	27.031M	28.032M	20.353M	9.457M	9.440M	9.159M
EPS Basic	-1.71	-0.70	-0.30	-0.46	-0.25	-0.40	-0.08	-0.46	-3.66
EPS Diluted	-1.72	-0.71	-0.30	-0.46	-0.25	-0.40	-0.08	-0.46	-3.66
Shares Outstanding	178.880M	178.880M	174.264M	174.945M	173.381M	170.506M	162.121M	165.612M	154.173M
Diluted Shares Outstanding	178.964M	178.964M	174.264M	174.945M	173.381M	170.506M	162.121M	165.612M	154.173M

TEM Annual Income Statement (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Gross Profit	885.687M	381.113M	286.175M	130.186M	83.644M	28.714M	16.042M
Revenue	1.272B	693.398M	531.822M	320.668M	257.853M	188.004M	62.057M
Cost of Goods Sold	386.102M	312.285M	245.647M	190.482M	174.209M	159.290M	46.015M
Gross Profit Margin	69.6%	55.0%	53.8%	40.6%	32.4%	15.3%	25.9%
Total Operating Expenses	1.124B	1.072B	482.258M	395.628M	327.355M	222.168M	135.823M
Research & Development	146.107M	316.844M	185.498M	162.251M	128.351M	91.276M	56.861M
Selling, General & Administrative	731.738M	755.351M	296.760M	233.377M	199.004M	130.892M	78.962M
Operating Income (EBIT)	-238.635M	-691.082M	-196.083M	-265.442M	-243.711M	-193.454M	-119.781M
Operating Margin	-18.8%	-99.7%	-36.9%	-82.8%	-94.5%	-102.9%	-193.0%
Income Before Tax (EBT)	-296.712M	-705.543M	-213.830M	-289.745M	-259.192M	-209.854M	-114.951M
Interest Income	12.628M	11.084M	7.601M	3.032M	623K	1.495M	4.860M
Interest Expense	70.267M	53.653M	46.869M	21.894M	15.184M	18.929M	28K
Other Income/Expense	-58.077M	-14.461M	-17.747M	-24.303M	-15.481M	-16.400M	4.830M
Net Income	-245.028M	-705.809M	-214.118M	-289.811M	-259.192M	-209.854M	-114.951M
Income Tax Expense	-51.684M	266K	288K	66K	0.00	0.00	0.00
Net Profit Margin	-19.3%	-101.8%	-40.3%	-90.4%	-100.5%	-111.6%	-185.2%
EBITDA	-222.357M	-610.417M	-133.328M	-236.846M	-219.523M	-169.373M	-99.903M
EBITDA Margin	-17.5%	-88.0%	-25.1%	-73.9%	-85.1%	-90.1%	-161.0%
Depreciation & Amortization	4.088M	37.245M	33.332M	30.410M	23.881M	23.052M	15.020M
EPS Basic	-1.41	-4.60	-1.73	-1.97	-1.75	-1.49	-0.92
EPS Diluted	-1.41	-4.60	-1.73	-1.97	-1.75	-1.49	-0.92
Shares Outstanding	174.264M	162.121M	154.173M	169.876M	169.876M	169.876M	160.708M
Diluted Shares Outstanding	174.264M	162.121M	154.173M	169.876M	169.876M	169.876M	160.708M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Tempus AI, Inc.

Tempus AI, Inc. functions as a pioneering health technology enterprise. It specializes in delivering advanced diagnostic services, including cutting-edge genomic sequencing, PCR analysis, molecular genotyping, and various other anatomical and molecular pathology assessments. These vital services are provided to a diverse clientele, including medical practitioners, pharmaceutical companies, biotechnology innovators, scientific researchers, and other collaborating entities. The company offers "Insights," a licensed repository of de-identified clinical, molecular, and imaging data, complemented by a comprehensive suite of analytical and cloud-based computing services, primarily aimed at pharmaceutical and biotechnology firms. Additionally, its "Trials" program facilitates clinical trial matching services specifically for pharmaceutical companies. Tempus AI also manages several other platforms: "Next"; "Algos," a collection of algorithm-driven tests focused on oncology; "Hub," a versatile desktop and mobile application for ordering, managing, and receiving test results for patients; and "Lens," a dedicated portal enabling researchers and scientists to discover, access, and analyze the extensive Tempus dataset. Further demonstrating its commitment to innovation, Tempus AI has formed strategic alliances with AstraZeneca and Pathos AI, Inc. for the co-development of oncological therapeutic initiatives. Established in 2015, the company was initially known as Tempus Labs, Inc. before officially rebranding to Tempus AI, Inc. in January 2023. Its operations are based out of Chicago, Illinois.

Chicago, IL

2,400 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials